Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_383571
Proper Citation: GeneTex Cat# GTX72366, RRID:AB_383571
Target Antigen: Laminin B1 [LT3] antibody
Host Organism: rat
Clonality: monoclonal
Comments: Discontinued; manufacturer recommendations: For IHC-Fr: Use at a dilution of 1:400. For IP: Use at a dilution of 1:400. For WB: Use at a dilution of 1:200. Not tested in other applications. Optimal dilutions/concentations should be determined by the researcher., Immunofluorescence, IHC (Frozen sections), Immunoprecipitation, Western blot. The usefulness of this product in other applications has not been determined., IF, IHC-Fr, IP, WB; Immunohistochemistry - frozen; Immunofluorescence; Immunoprecipitation; Western Blot; Immunohistochemistry
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Laminin B1 [LT3] antibody.
Discontinued
Discontinued at GeneTex
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.